Obesity and Cardiac diseases

Obesity is a major contributor to the prevalence of cardiovascular disease in the developed world, and same level of attention as other risk factors of coronary artery disease. It is a chronic metabolic disorder associated with cardiovascular disease and increased morbidity and mortality. It implicates a corresponding increase in the number of individuals afflicted with the metabolic syndrome, which defines the obese patient as being "at risk.", by modifying lipids, decreasing blood pressure, and decreasing levels of glycaemia, proinflammatory cytokines, and adhesion molecules, weight loss may prevent the progression of atherosclerosis or the occurrence of acute coronary syndrome events in the obese high-risk population.

  • Obesity and Heart Failure
  • Atrial fibrillation
  • Ischaemic Heart Disease
  • Obstructive Sleep Apnea
  • Systolic and diastolic dysfunction
  • Dyslipidaemia

Related Conference of Obesity and Cardiac diseases

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
September 19-20, 2024

7th World Heart and Brain Conference

London, UK
September 19-20, 2024

6th Annual Conference on Vascular Medicine

London, UK
October 17-18, 2024

8th Annual Heart Rhythm Conference

Barcelona, Spain
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland

Obesity and Cardiac diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in